𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men

✍ Scribed by M. S. Lewitt; A. Hilding; C.-G. Östenson; S. Efendic; K. Brismar; K. Hall

Publisher
Springer
Year
2008
Tongue
English
Weight
311 KB
Volume
51
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential expression of insulin-like
Differential expression of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in the diabetic rat
✍ Jiangming Luo; Liam J. Murphy 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 682 KB

Multiple factors contribute to the growth retardation which is a characteristic feature of uncontrolled diabetes. In this report we have examined the effects of streptozotocin-induced (STZ) diabetes on expression of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-

The role of insulin-like growth factor-I
The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes
✍ Swapnil N. Rajpathak; Marc J. Gunter; Judith Wylie-Rosett; Gloria Y. F. Ho; Robe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

This review addresses the possible role of the insulin-like growth factor (IGF)axis in normal glucose homoeostasis and in the etiopathogenesis of type 2 diabetes. IGF-I, a peptide hormone, shares amino acid sequence homology with insulin and has insulin-like activity; most notably, the promotion of

Serum levels of growth hormone-binding p
Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus
✍ G. Massa; L. Dooms; R. Bouillon; M. Vanderschueren-Lodeweyckx 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 577 KB

Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b

Advanced glycosylation end products (AGE
Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with Type 2 diabetes mellitus
✍ Ma. Eugenia Garay-Sevilla; Laura Eugenia Nava; Juan Manuel Malacara; Kazimierz W 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

Background Advanced glycosylation end product (AGE) formation is a major mechanism for the development of complications in diabetes, and the possible roles of insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) are not clearly established. ## Methods We examined the associati